Solid Biosciences (SLDB) Total Non-Current Liabilities (2018 - 2026)
Solid Biosciences (SLDB) reported Total Non-Current Liabilities of $17.92 million for Q2 2026, down 11.1% from $20.16 million a year earlier and down 3.0% from the prior quarter.
Powered by 
Analysis
Solid Biosciences (SLDB) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
At the end of FY2025, Solid Biosciences posted Total Non-Current Liabilities of $19.06 million, down 9.9% from FY2024.
- Total Non-Current Liabilities has declined for three consecutive years, with a five-year compound annual growth rate of -12.8% (FY2020 to FY2025).
- By year, Total Non-Current Liabilities came in at $21.16 million in FY2024 (-11.6%), $23.94 million in FY2023 (-50.6%) and $48.49 million in FY2022.
- The Q2 2026 figure ranks as the lowest quarterly Total Non-Current Liabilities since Q4 2018.
- Year over year, Total Non-Current Liabilities has now declined in each of the last five quarters, with an average decline of 11.1% over the last six quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at $18.48 million (Q1 2026), $19.06 million (Q4 2025) and $19.62 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Solid Biosciences | 931.82 Mn | -250.53 Mn | - | 17.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.92 Mn |
| Mar 31, 2026 | 18.48 Mn |
| Dec 31, 2025 | 19.06 Mn |
| Sep 30, 2025 | 19.62 Mn |
| Jun 30, 2025 | 20.16 Mn |
| Mar 31, 2025 | 20.66 Mn |
| Dec 31, 2024 | 21.16 Mn |
| Sep 30, 2024 | 21.95 Mn |
| Jun 30, 2024 | 23.05 Mn |
| Dec 31, 2023 | 23.94 Mn |
| Dec 31, 2022 | 48.49 Mn |
| Dec 31, 2020 | 37.78 Mn |
| Dec 31, 2018 | 13.34 Mn |
| Sep 30, 2018 | 10.64 Mn |
| Jun 30, 2018 | 8.68 Mn |
| Mar 31, 2018 | 9.93 Mn |
API Access
Solid Biosciences Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=SLDB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "SLDB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=SLDB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();